Healthcare provider profile · identity verified

Toby R Sadkin, MD

Family Practice · ST ALBANS, VT · NPI 1750346839

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	391	99
Pantoprazole Sodium	Pantoprazole Sodium	334	75
Gabapentin	Gabapentin	271	56
Metoprolol Succinate	Metoprolol Succinate	228	53
Lisinopril	Lisinopril	202	54
Omeprazole	Omeprazole	180	48
Amlodipine Besylate	Amlodipine Besylate	177	48
Levothyroxine Sodium	Levothyroxine Sodium	170	43
Losartan Potassium	Losartan Potassium	158	48
Simvastatin	Simvastatin	154	37
Trazodone Hcl	Trazodone Hcl	139	27
Metformin Hcl	Metformin Hcl	128	28
Duloxetine Hcl	Duloxetine Hcl	115	30
Furosemide	Furosemide	115	30
Lorazepam	Lorazepam	113	24
Meloxicam	Meloxicam	111	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	15
Hydrochlorothiazide	Hydrochlorothiazide	107	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	101	13
Mirtazapine	Mirtazapine	96	20
Eliquis	Apixaban	79	15
Potassium Chloride	Potassium Chloride	75	15
Ozempic	Semaglutide	73	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	73	18
Torsemide	Torsemide	70	suppressed
Citalopram Hbr	Citalopram Hydrobromide	69	14
Bupropion Xl	Bupropion Hcl	64	20
Pregabalin	Pregabalin	63	18
Albuterol Sulfate Hfa	Albuterol Sulfate	61	24
Jardiance	Empagliflozin	61	12
Trulicity	Dulaglutide	56	suppressed
Alendronate Sodium	Alendronate Sodium	55	17
Chlorthalidone	Chlorthalidone	55	16
Metformin Hcl Er	Metformin Hcl	55	11
Warfarin Sodium	Warfarin Sodium	53	suppressed
Clonazepam	Clonazepam	52	suppressed
Paroxetine Hcl	Paroxetine Hcl	49	suppressed
Atenolol	Atenolol	44	11
Tramadol Hcl	Tramadol Hcl	44	suppressed
Ventolin Hfa	Albuterol Sulfate	44	suppressed
Nifedipine Er	Nifedipine	42	12
Spironolactone	Spironolactone	41	19
Diazepam	Diazepam	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Carvedilol	Carvedilol	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	15
Methadone Hcl	Methadone Hcl	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	11
Topiramate	Topiramate	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Famotidine	Famotidine	35	suppressed
Meclizine Hcl	Meclizine Hcl	35	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	34	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Cephalexin	Cephalexin	32	17
Allopurinol	Allopurinol	31	suppressed
Fluconazole	Fluconazole	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	23
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Temazepam	Temazepam	26	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Ibuprofen	Ibuprofen	23	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	14
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Nystatin	Nystatin	20	suppressed
Prednisone	Prednisone	20	suppressed
Valsartan	Valsartan	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Colchicine	Colchicine	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Baclofen	Baclofen	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	13	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Endocet	Oxycodone Hcl/Acetaminophen	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error